The increasing complexity of biologic medicines is transforming pharmaceutical manufacturing across the United States. As biotechnology companies accelerate the development of monoclonal antibodies, recombinant proteins, vaccines, and advanced cell-based therapies, demand for specialized contract manufacturing services continues to rise. The latest Polaris Market Research report indicates that...